Clinical Results1,2
A 336-subject randomized and double-blind clinical trial investigating the effect of dermaPACE Shockwave treatment on Diabetic Foot Ulcers demonstrated superiority in wound healing and wound area reduction when comparing the dermaPACE System treated patients against the control patients, with an excellent safety profile. The dermaPACE System showed superior results vs. control:
- In wound closure at 24 weeks (37.79% vs. 26.22%; p=0.023)
- In the overall rate to wound closure (p=0.0346)
- In the reduction in area (cm2) of the wound at six weeks (p=0.003) through 24 weeks (p=0.047)